In order to continue strengthening its expansion in North America, Kayentis has appointed Guy Maestre as vice-president of its US operations.
Maestre has more than 20 years of biopharmaceutical industry experience with an emphasis on general management, as well as the development and marketing of new drugs on a global basis.
Most recently he was chief executive officer at Phenotech.
Prior to this, Maestre served as president and chief executive officer of Novactyl.
Maestre will initially be promoting Clin Form, a system for the data capture of clinical report forms and patient diaries, to help build North American operations for Kayentis.
